ArticleNeuro-oncology2019

The anticipated revision of the grading criteria for adult isocitrate dehydrogenase-mutant diffuse glioma within the neuro-oncology community.

Takashi KomoriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.